Podiatrists in Waterford, CT Accepting Medicare

7 Podiatrists found. Showing 1 - 7

Dr. Kenneth R Kierstein, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 196 Parkway S, Suite 302, Waterford, CT 06385 Phone: 860-447-1488    Fax: 860-447-1489

Dr. Joseph William Difrancesca, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 196 Parkway S, Suite 302, Waterford, CT 06385 Phone: 860-447-1488    Fax: 860-447-1489

Allegheny Foot & Ankle Center, Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 914 Hartford Tpke, Waterford, CT 06385 Phone: 860-443-3838    Fax: 860-443-3839

Dr. John Michael Gaetano, DPM FACFAS Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 914 Hartford Turnpike, Waterford, CT 06385 Phone: 860-443-3838    Fax: 860-443-3839

Drs Kierstein & Difrancesca Dpm, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 196 Parkway S, Suite 302, Waterford, CT 06385 Phone: 860-447-1488    Fax: 860-447-1489

Drs Kierstein & Difrancesca Dpm, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 196 Parkway S, Suite 302, Waterford, CT 06385 Phone: 860-447-1488    Fax: 860-447-1489

Dr. Jeffrey Michael Kierstein, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 196 Parkway S, Suite 302, Waterford, CT 06385 Phone: 860-447-1488    Fax: 860-447-1489

News Archive

SafeBridge Consultants validates improved hygiene air sampling and analytical method for naproxen sodium

SafeBridge® Consultants, Inc. headquartered in Mountain View, California announced today that its industrial hygiene analytical laboratory has recently validated an industrial hygiene air sampling and analytical method with improved analytical sensitivity for measurement of naproxen sodium on filters. SafeBridge now has a validated method that will detect as low as 20 picograms per filter in an air sample collected on appropriate media. This limit of detection is four (4) to five (5) times lower than methods available from other commercial laboratories.

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

Enzo Biochem to market GeneNews' ColonSentry in New York and New Jersey

Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has entered into an agreement with GeneNews (TSX: GEN), of Toronto, Canada, for exclusive rights to market GeneNews' ColonSentry™, a proprietary blood test for colorectal cancer, in the states of New York and New Jersey.

Researchers aim to assess preparedness of clinicians in communicating end-of-life issues

Delivering news about end-of-life issues is one of the most difficult tasks clinicians encounter in medical practice. Researchers from the Texas Medical Center on behalf of the ETHICS study investigators, in Houston, Texas, aimed to assess how prepared health-care providers feel in communicating end-of-life issues and determining if proper training had been given to health-care providers.

About 31 percent of low-income children ages 2 to 5 have dental cavities that don't get treated

If untreated, the infection (dental caries) that causes tooth decay and cavities can also lead to pain, tooth loss and more serious infections. The American Academy of Pediatric Dentistry recommends a dental check-up at least twice a year for most children. Some children need more frequent dental visits because of increased risk of tooth decay, unusual growth patterns or poor oral hygiene.

Read more Medical News

› Verified 3 days ago